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Background: Analgesics are among the most commonly consumed drugs by the world populations. Within the
broader context of self-medication, pain relief occupies a prominent position. Our study was to ascertain the
prevalence of self-medication with analgesics among the Spanish population and to identify predictors of
self-medication, including psychological disorders, psychological dysfunction, mental health status, and
sociodemographic and health-related variables.
Methods: We used individualized secondary data retrieved from the 2009 European Health Interview Survey (EHIS)
for Spain to conduct a nationwide, descriptive, cross-sectional pharmacoepidemiology study on self-medication
with analgesics among adults (individuals aged at least 16 years) of both genders living in Spain. A total of 7,606
interviews were analysed. The dichotomous dependent variables chosen were the answers “yes” or “no” to the
question In the last 2 weeks have you taken the medicines not prescribed for you by a doctor for joint pain, headache,
or low back pain?” Independent variables were sociodemographic, comorbidity, and healthcare resources.
Results: A total of 7,606 individuals reported pain in any of the locations (23.7%). In addition, analgesic consumption
was self-prescribed in 23.7% (1,481) of these subjects. Forty percent (40.1%) of patients self-medicated for headache,
15.1% for low back pain, and 6.7% for joint pain. The variables significantly associated with a greater likelihood of self-
medication of analgesics, independently of pain location were: age 16–39 years (2.36 < AOR < 3.68), higher educational
level (1.80 < AOR <2.21), psychological disorders (1.56 < AOR < 1.98), and excellent/good perception of health status
(1.74 < AOR < 2.68). In subjects suffering headache, self-prescription was associated with male gender (AOR 2.13) and
absence of other comorbid condition (AOR 4.65).
Conclusions: This pharmacoepidemiology study constitutes an adequate approach to analgesic self-medication use in
the Spanish population, based on a representative nationwide sample. Self-prescribed analgesic consumption was
higher in young people with higher educational level, higher income, smoker, and with psychological disorders and
with a good perception of their health status independently of the location of pain.Background
Pain is a common human experience that is explained
through a complex study of people within everyday envi-
ronments and social context [1,2]. It is one of the main
causes of morbidity worldwide affecting 10% to 30% of
the European adult population; however, some studies
have reported prevalence up to 50% [3-7]. In North
America, the prevalence rate is 31% [8].* Correspondence: pilar.carrasco@urjc.es
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article, unless otherwise stated.Pain is studied from different viewpoints. Associated
psychological aspects can affect the consumption of an-
algesics. In fact, depression, anxiety and personality traits
should be taken into consideration when analyzing how
pain is perceived [9,10]. Self-care is practiced daily
throughout by several people around the world. Self-
medication is viewed as responsible involvement by pri-
vate individuals in caring for themselves or members of
their family [11]. This circumstance has been accentu-
ated by the growing replacement of prescribed medi-
cines by over-the-counter (OTC) remedies [12,13].
Pain relief occupies a prominent position within the
broader context of self-medication [14,15]. Analgesicsd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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and it is estimated that millions of people in the United
States, Australia, and Europe use OTC analgesics on a
daily basis [16-18]. A Spanish study using data from the
2003 Spanish National Health Survey showed that,
among individuals consuming analgesics, 39.4% were
self-medicating [19].
Pain interrupts attention and interferes with daily life.
Both psychological and social factors have been shown
to predict outcome in individuals with chronic pain. In
fact, depression is a common comorbidity, yet it is
undiagnosed in clinical practice [20,21]. Given that psy-
chiatric disorders are better diagnosed by structured in-
terviews as part of the clinical practice, it is difficult to
obtain reliable results in population-based studies. Some
authors have used the generic SF-36 quality of life ques-
tionnaire in order to differentiate between patients with
and without psychological disorders [22]. Further, health
surveys are significantly commended as they collect
valuable information related to musculoskeletal pain,
which is not available from most other sources of
information.
Therefore, the aims of the current study were: first, to
ascertain the prevalence of self-medication with analge-
sics among the Spanish population; second, to identify
variables associated to self-medication, including psy-
chological disorders, mental health status, and socio-
demographic and health-related variables.Methods
We conducted a nationwide, descriptive, cross-sectional
epidemiologic study on self-medication among adults
(individuals aged at least 16 years) of both genders living
in Spain. This study was based on data obtained from
the European Health Interview Survey for Spain (2009).
As this study was conducted using de-identified public-
use databases, it was not necessary to have the approval
of an ethics committee.The 2009 European Health Interview Survey for Spain
(EHISS)
The European Health Interview Survey (EHIS) was pro-
posed by the European Commission to European Union
Member States to create a health information system
through comprehensive and coordinated surveys con-
ducted in the European Statistical System under the re-
sponsibility of “Eurostat”. In such a way, all European
Union States would share common guidelines for the
survey modules (health determinants, health status,
health care, background variables) and designs and based
on a common questionnaire. The EHIS is implemented
every five years, with the first wave completed between
2008 and 2009 [23].In Spain, the EHIS was conducted by the National Sta-
tistics Institute (Instituto Nacional de Estadística, INE)
under the aegis of the Spanish Ministry of Health and
Social Affairs in 2009. This survey is a computer-aided
home-based personal interview including nationwide
representative sample of civilian, non-institutionalized
population aged ≥ 16 years and residing in primary fam-
ily dwellings (households) in Spain. Study subjects were
selected by means of probabilistic multistage sampling,
with the first-stage units being census sections and the
second-stage units being primary family dwellings. De-
tails of EHISS methodology are described elsewhere
[24]. The data collection period ranged from April 2009
to March 2010. The analysis was performed in January
2013.
Analgesic consumption definition
The dependent variable of the current study was created
using the following two questions: “In the last two weeks
have you taken those medicines prescribed for you by a
doctor for joint pain, headache, or low back pain?”, or,
“In the last two weeks have you taken the medicines not
prescribed for you by a doctor for joint pain, headache,
or low back pain?” An affirmative answer to the first
question was considered as “prescribed analgesic use”.
An affirmative answer to the second question was classi-
fied as “self-medicated analgesic use”. Total analgesic
use included those with both prescribed and self-
medicated drugs.
Socio-demographic variables, lifestyle habits and
co-morbid conditions
The following independent variables were included in
the analysis. Main socio-demographic features including
sex, age, marital status (married or not married), educa-
tional level (classified as no formal education, junior
school or high school), occupational status (unemployed,
employed or inactive), and monthly income.
Within lifestyle habits, smoking habit differentiated
between current smokers or non-smokers. The alcohol
consumption was measured using the question “Have
you consumed alcoholic drinks in the previous 2 weeks?”
Individuals were also asked for: “Do you practice any
leisure time physical activity for at least 3 day per week?
(Answer: active or inactive) Finally, the body mass index
(BMI) was calculated from the self-reported body weight
and height. Individuals with a BMI ≥ 30 were classified
as obese.
Self-perceived health status was assessed with the fol-
lowing question: “How did you self-perceive your health
status over the previous 12 months?” Subjects described
health status as excellent, good, fair, poor or very poor.
This variable was dichotomized into two: excellent/good
or fair/poor/very poor self-perceived health status. Mental
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Short-Form SF-36 quality of life questionnaire: psycho-
logical dysfunction and mental health status. Both indica-
tors are obtained through 9 items which are scored from 0
to 100 points, where higher scores represent better mental
health [25].
To identify individuals with associated chronic condi-
tions, we used self-reported affirmative answer to the
presence of any physician diagnosed concomitant dis-
eases including hypertension, hypercholesterolemia, re-
spiratory disease (asthma and chronic bronchitis), heart
disease, diabetes, and cancer. We recorded whether pa-
tients had none, 1–2, or > 2 diseases. The presence of
depression or anxiety (psychological disorders) was
assessed using the following 2 questions: “Have you suf-
fered from depression and/or anxiety the previous
12 months?”, and, “Has your medical doctor confirmed
the diagnosis?”
Statistical analysis
Self-medication patterns were identified using descriptive
statistics of the main study variables by calculating the
prevalence of total use and self-medication with analgesics
for joint pain, headache, low back pain, and any pain
localization during the years 2009–2010. Pearson χ2 test
was used for the bivariate comparison of proportions.
Mean scores were also obtained for those variables
from SF-36 (psychological dysfunction and mental
health status) by calculating the difference in means be-
tween those who consume analgesics and those who did
not for each of the pain localizations analyzed in the
study, as well as the difference in means between those
who consumed prescription analgesics and those who
were self-medicated with analgesics for joint pain, head-
ache, low back pain, and any localization.
To estimate the independent effect of the study vari-
ables on self-medication with analgesic drugs, we ob-
tained the corresponding adjusted odds ratio (AOR) and
the 95% Confidence Interval (95% CI) by means of multi-
variate logistic regression analysis. All variables showing a
significant association in the bivariate analysis were in-
cluded in the multivariate analysis, along with those vari-
ables that were considered relevant according to scientific
literature. Four models were generated, as follows: one to
identify factors associated with self-medication using anal-
gesic drugs for joint pain; a second model to identify those
factors predicting self-medication with analgesic drugs for
headache; a third model for self-medication with analgesic
drugs for low back pain; and a fourth logistic regression
model to identify those factors associated with self-
medication with analgesic drugs for pain at any pain
localization. Estimates were made using the svy (survey
commands) functions of the STATA program (STATA
Corp, College Station, Texas, USA), which enabled us toincorporate the sampling design and weights into all stat-
istical calculations (descriptive, χ2, logistic regression).
Statistical significance was set at a 2-tailed α < 0.05.
Results and discussion
Our results were based on data obtained from 7,606
subjects who answered the questions regarding con-
sumption of analgesic medication (prescribed or self-
medicated) in the 2 weeks immediately preceding the
survey for any of the localizations analyzed. The sample
represented 31.8% of subjects interviewed in the EHISS.
Table 1 shows data on total analgesic consumption (with
or without medical prescription) for joint pain headache,
and low back pain and for any localization, according to
socio-demographic characteristics, lifestyle, and health-
related study variables. The results showed that 19.9% of
the population consumed analgesics for low back pain,
12.6% for joint pain, and 10.9% for headache. The preva-
lence of consumption for pain at any localization was
39.8% for women and 23.5% for men (P < 0.05). Values
for the consumption of analgesics were significantly
higher when subjects were aged >65 years, had >2
chronic conditions, a chronic mental illness (anxiety and
depression) or worse self-rated health status (P < 0.05).
When pain location was analyzed, analgesic consump-
tion was higher in women than men, individuals with >2
chronic conditions, subjects with psychological disor-
ders, and those subjects reporting fair/poor/very poor
health status (P < 0.05). It is noteworthy that consump-
tion of analgesics was also higher in smokers and
drinkers compared to non-smokers and no drinkers (P <
0.05). Table 1 summarizes the average scores for psycho-
logical dysfunction and mental health status. Subjects
exhibiting joint pain who consume analgesics had the
lowest scores in both domains of the SF-36.
Analgesic drug consumption was self-prescribed in
23.7% (1,481) of the sample. Table 2 shows the results of
the 4 analyses performed to determine the proportion of
analgesic self-medication for each of pain localizations
according to socio-demographic characteristics, lifestyle
and health-related variables. Men self-medicated their
analgesic consumption than women (P < 0.05) and self-
medication was significantly higher in the population
aged 16–39 years than in remaining age groups (P <
0.05). Analgesic self-medication was more frequent in
smokers and drinkers than in non-smokers and those sub-
jects who not drinking. Additionally, more over-the-count
medication was consumed by subjects reporting excellent/
good health status and no chronic diseases (P < 0.05).
When analgesic self-medication was analyzed by loca-
tion, those experiencing headaches exhibited higher self-
prescription (40.1%) than those suffering low back pain
(15.1%) or joint pain (6.7%). The frequency of self-
medication was higher in men than in women, in those
Table 1 Prevalence of analgesic consumption (prescribed and self-medicated) for joint pain, headache, low back pain











N % N % N % N %
Age*+Ɨǂ
16-39 176 2.3 738 10.6 1025 14.5 1662 23.4
40-64 1232 12.8 1086 10.9 1963 20.7 3058 32.6
>65 2009 33.5 590 9.6 1807 29.3 2886 47.4
Sex*+Ɨ
Male 820 7.2 688 7.2 1532 14.4 2445 23.5
Female 2597 17.9 1726 14.5 3263 25.1 5161 39.8
Marital status*Ɨǂ
Not married 1641 10.8 1104 10.8 2224 18.8 3519 29.9
Married 1776 14.0 1310 11.0 2571 20.7 4087 33.3
Educational level*+Ɨǂ
No formal education 1353 33.2 488 12.4 1306 32.1 1993 49.1
Junior school 1158 17.7 549 9.6 1291 21.4 2093 34.8
High school 906 6.2 1377 11.1 2198 16.6 3520 26.8
Occupational status*+Ɨǂ
Unemployed 209 8.44 269 11.58 446 18.80 671 27.97
Employed 866 6.99 1205 10.91 1952 16.97 3155 27.59
Inactive 2342 23.61 940 10.73 2397 25.15 3780 40.26
Monthly income*Ɨǂ
<850€ 932 22.2 417 12.0 999 26.1 1540 40.3
850-1400€ 875 15.8 520 11.0 1180 22.6 1786 34.6
>1400€ 1094 9.6 1100 11.0 1935 18.5 3111 29.9
Smoking habit*+Ɨǂ
Non smoker 2935 14.9 1747 10.6 3683 20.8 5860 33.2
Smoker 482 7.1 667 11.8 1112 17.7 1746 28.4
Alcohol consumption*+Ɨǂ
No 2552 12.9 1863 11.9 3572 20.6 5648 33.0
Yes 610 9.6 434 8.2 931 16.1 1541 26.7
Physical activity*Ɨǂ
Inactive 2167 15.1 1340 10.9 2891 22.0 4484 34.3
Moderate 1250 10.1 1074 10.9 1904 17.7 3122 29.3
Body Mass Index Kg/sq.m*Ɨǂ
<30 2148 10.3 1831 10.8 3392 18.4 5418 29.7
≥30 850 22.1 407 12.1 952 26.4 1491 41.2
Self-assessment of health status*+Ɨǂ
Very good/Good 859 4.6 1302 8.8 2079 12.9 3632 22.7
Fair/Poor/Very poor 2558 35.5 1112 17.1 2716 39.7 3974 57.7
Number of chronic conditions*+Ɨǂ
None 1839 9.0 1631 10.1 3035 17.3 4961 28.3
1-2 1367 23.0 691 13.4 1550 27.1 2360 42.2
>2 211 44.9 92 18.7 210 44.7 285 60.0
Psychological disorders*+Ɨǂ
No 2361 10.1 1784 9.6 3580 17.4 5911 28.8
Yes 1056 31.8 630 21.3 1215 38.4 1695 54.1
Psychological dysfunction*+Ɨǂ (mean. se) [mean difference] 64.3 (0.5) [−14.4] 68.2 (0.6) [−9.88] 67.9 (0.4) [−11.4] 69.8 (0.3) [−10.48]
Positive mental health*+Ɨǂ (mean. se) [mean difference] 50.6 (0.5) [−20.3] 57.5 (0.6) [−2.18] 56.2 (0.4) [−15.1] 58.6 (0.3) [−14.18]
TOTAL 3417 12.6 2414 10.9 4795 19.9 7606 31.8
European Health Interview Survey (EHIS, 2009).
*Analgesic consumption for joint pain, +Analgesic consumption for headache.
ƗAnalgesic consumption for low back pain, ǂTotal analgesic consumption for any localization.
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logical disorders, and in those subjects reporting excel-
lent/good health status (P < 0.05). The highest values for
self-medication were always recorded for individuals suf-
fering from headaches.Table 2 also shows the average scores obtained for psy-
chological dysfunction and mental health status for use
of analgesics without prescription. Self-medication with
analgesics for joint pain was the variable with the lowest
scores in both domains of the SF-36.
Table 2 Proportion of self-prescribed analgesic medication for joint pain, headache, low back pain and any localization






for low back pain
Self-medication
for any localization
N % N % N % N %
Age*+Ɨǂ
16-39 42 19.8 406 57.2 270 28.0 655 41.5
40-64 106 8.8 370 37.2 253 13.7 664 23.6
>65 61 3.2 49 8.1 68 4.1 162 5.7
Sex+Ɨǂ
Male 58 7.5 349 55.2 225 17.0 587 27.8
Female 151 6.4 476 32.8 366 14.1 894 21.3
Marital status+Ɨǂ
Not married 96 6.7 382 45.2 289 19.0 697 28.1
Married 113 6.7 443 36.2 302 12.4 784 20.6
Educational level*+Ɨǂ
No formal education 38 2.9 47 11.3 52 4.6 115 6.4
Junior school 59 5.4 135 29.5 84 7.6 255 14.4
High school 112 12.7 643 50.7 455 23.2 1111 35.2
Occupational status*+Ɨǂ
Unemployed 16 8.15 98 36.62 58 14.10 151 23.20
Employed 95 10.05 548 49.85 393 21.39 948 32.76
Inactive 98 4.83 179 24.54 140 8.26 382 13.32
Monthly income*+Ɨǂ
<850€ 28 3.1 69 21.2 53 6.4 139 11.4
850-1400€ 42 4.9 152 33.5 122 11.1 282 18.0
>1400€ 96 9.1 455 45.7 342 19.8 815 29.3
Smoking habit*+Ɨǂ
Non smoker 159 5.8 506 34.3 370 12.9 946 19.8
Smoker 50 11.3 319 53.0 221 21.7 535 34.9
Alcohol consumption+Ɨǂ
No 146 6.2 605 39.0 428 15.1 1075 23.8
Si 54 9.2 209 52.3 147 18.7 375 28.0
Physical activity*+Ɨǂ
Inactive 108 5.1 408 37.0 287 12.7 736 20.3
Moderate 101 9.1 417 43.2 304 18.2 745 27.8
Body Mass Index Kg/sq.m*+Ɨǂ
<30 157 7.8 699 43.6 491 17.1 1238 27.0
≥30 34 4.3 95 27.6 71 8.8 175 13.9
Self-assessment of health status*+Ɨǂ
Very good/Good 106 12.8 690 56.7 466 25.3 1173 36.2
Fair/Poor/Very poor 103 4.5 135 15.9 125 5.7 308 9.7
Number of chronic conditions*+Ɨǂ
None 153 9.4 686 47.1 473 18.6 1206 28.7
1-2 53 3.7 136 25.3 112 8.9 263 13.9
>2 3 1.4 3 3.3 6 2.8 12 4.2
Psychological disorders t*+Ɨǂ
No 168 7.9 751 47.9 521 17.6 1326 27.0
Si 41 3.8 74 13.6 70 6.8 155 10.6
Psychological dysfunction+ǂ (mean. se) [mean difference] 69.80 (2.1) [5.8] 76.94 (0.8) [14.6] 74.41 (1.0) [7.7] 76.14 (0.6) [8.3]
Positive mental health*+ǂ (mean. se) [mean difference] 56.76 (2.5) [6.6] 67.55 (0.8) [16.9] 65.54 (1.1) [11.0] 66.56 (0.6) [10.4]
TOTAL 209 6.7 825 40.1 591 15.1 1481 23.7
European Health Interview Survey (EHIS, 2009).
*Self-medication for joint pain, +Self-medication for headache.
ƗSelf-medication for low back pain, ǂSelf-medication for any localization.
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lysis (adjusted odd ratio) to identify predictors of self-
medication with analgesics are summarized in Table 3.
The variables that were significantly associated with a
greater likelihood of self-medication of analgesics for
joint pain were age (aged 16–39 years, OR 3.16 95% CI1.75-5.71), high educational level (OR 2.21, 95% CI 1.31-
3.71), psychological disorders (OR 1.56, 95% CI 1.01-
2.46), and excellent/good perception of health status
(OR 1.74, 95% CI 1.74-2.49). In subjects suffering head-
ache, analgesic self-prescription was associated with age
(aged 16–39 years, OR 3.68, 95% CI 2.25-6.03), male
Table 3 Factors associated with analgesic self-medication among consumers with joint pain, headache, low back pain









AOR, 95% CI AOR, 95% CI AOR, 95% CI AOR, 95% CI
Age
>65 1 1 1 1
40-64 1.78 (1.18-2.70) 2.55 (1.63-3.99) 1.67 (1.12-2.47) 2.38 (1.82-3.09)
16-39 3.16 (1.75-5.71) 3.68 (2.25-6.03) 2.36 (1.54-3.62) 3.71 (2.77-4.97)
Sex
Female 1 1 1
Male NS 2.13 (1.66-2.73) NS NS
Educational level
No formal education 1 1 1 1
Junior school 1.37 (0.81-2.33) 1.46 (0.85-2.53) 1.01 (0.62-1.62) 1.29 (0.93-1.80)
High school/University 2.21 (1.31-3.71) 1.87 (1.09-3.19) 1.80 (1.15-2.82) 1.89 (1.37-2.62)
Marital status
Married 1 1 1
Not married NS NS 1.44 (1.11-1.87) NS
Monthly income
<850€ 1 1 1 1
850-1400€ NS NS 1.24 (0.82-1.89) 1.03 (0.77-1.38)
>1400€ NS NS 1.70 (1.14-2.54) 1.33 (1.01-1.75)
Smoking habit
Non smoker 1 1 1 1
Smoker NS NS 1.28 (1.01-1.66) 1.34 (1.12-1.60)
Self-assessment of health status
Fair/Poor/Very poor 1 1 1 1
Very good/Good 1.74 (1.22-2.49) 2.38 (1.74-3.26) 2.68 (1.97-3.65) 2.24 (1.81-2.78)
Number of chronic conditions
>2 1 1 1 1
1-2 NS 3.45 (1.05-11.32) NS NS
None NS 4.65 (1.43-15.06) NS NS
Psychological disorders
No 1 1 1 1
Yes 1.56 (1.01-2.46) 1.98 (1.37-2.88) 1.61 (1.11-2.32) 1.62 (1.24-2.11)
European Health Interview Survey (EHISS, 2009) for Spain.
Data are expressed as adjusted odds ratio (AOR) and 95% confidence intervals (95% CI).
NS: non-significant association.
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tional level (OR 1.87, 95% CI 1.09-3.19), absence of
other comorbid condition (OR 4.65, 95% CI 1.43-15.06),
psychological disorders (OR 1.98, 95% CI 1.37-2.88), and
excellent/good perception of health status (OR 2.38, 95%
CI 1.74-3.26). Finally, the variables associated with a
greater likelihood of self-medication for low back pain
were age (aged 16–39 years OR 2.36, 95% CI 1.54-3.62),
high educational level (OR 1.80, 95% CI 1.15-2.82), to be
not married (OR 1.44, 95% CI 1.11-1.87), high monthly
income (OR 1.70, 95% CI 1.14-2.54), smoking (OR 1.28,
95% CI 1.01-1.66), psychological disorders (OR 1.61, 95%
CI 1.11-2.32) and excellent/good perception of health sta-
tus (OR 2.68, 95% CI 1.97-3.65).
When analyzed the variables associated with self-
prescription of consumption of analgesics for the pres-
ence of pain in any localization, 6 variables were present:
aged 16–39 years (OR 3.71, 95% CI 2.77-4.97), high edu-
cational level (OR 1.89, 95% CI 1.37-2.62), high monthly
income (OR 1.33, 95% CI 1.01-1.75), smoking (OR 1.34,95% CI 1.12-1.60), psychological disorders (OR 2.24, 95%
CI 1.81-2.78), and excellent/good perception of health sta-
tus (OR 1.62, 95% CI 1.24-2.11).
Analgesic drugs are worldwide used and are justified
and necessary in cases of intense and frequent pain [14].
The results of our study showed that 23.7% of Spanish
adults who consume analgesic medication use OTC
drugs. Our data is higher than the 13.6% found in
Finland [26], substantially lower than the 55% use of
OTC analgesics found in Australian adults [15] but simi-
lar than in American adults (33%) [18]. It seems that
self-prescription of analgesic drugs, i.e., OTC use is
highly prevalent in populations across the world.
A common denominator associated with OTC anal-
gesic drug consumption is the influence of gender. Al-
though some studies using similar methodology than
our study reported a higher probability of self-prescribed
analgesic drug consumption in women [18,27,28], gen-
der differences could be related to a higher prevalence of
headaches in women since headaches are associated with
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gesics [29,30]. Nevertheless, Krymchantowski et al.
found that men suffering chronic daily headache exhib-
ited higher medication use than women [31]. It is pos-
sible that gender differences in self-prescribed analgesic
consumption are related to several factors including spe-
cific co-morbid conditions and socio-cultural factors.
We found that subjects aged 19 to 39 years were al-
most 4 times as likely to use OTC analgesics for any
pain location as elderly people. Current results also
agree with previous studies. Stosic et al. showed a higher
self-prescribed analgesic consumption and use of OTC
drugs in Australian adults younger than 54 years old
compared to those older than 55 years [15]. Wilcox et al.
reported that American adults in the forties had a higher
OTC analgesic consumption [18]. Current and previous
results suggest that OTC drugs seem to be self-
prescribed in a greater manner in the mid-age of the life,
probably related to higher prevalence of pain syndromes
and higher educational level. In fact, our results revealed
that individuals taking OTC analgesics were young and
highly educated (university level). Spanish university
graduates were twice as likely to take OTC drug con-
sumption as those with lower educational level.
Klemenc-Ketis et al. found that 92% of Slovenian univer-
sity students reported the use of self-medication [28].
These results agree with several published studies where
OTC consumption was also associated with higher edu-
cational level [19,32,33]. Self-medication is more com-
mon among healthcare professionals (e.g. physicians,
nurses, and pharmacists) than in the general population
[34,35]. This can be related to the fact that healthcare
professionals have university studies in almost all
countries.
Further, a higher level of education can be related to a
higher monthly income. When variable monthly income
was analyzed, the results showed that subjects earning
more than €1400 per month were more likely to take
OTC analgesics, especially for back pain. These data are
consistent with those reported in a recent study con-
ducted in American adults where individuals with lower
income were less likely to consume OTC non-steroidal
anti-inflammatory drugs than those subjects with a
higher income [33]. It is possible that a higher educa-
tional level involves higher monetary income and both
variables are related to greater self-prescription con-
sumption for pain.
Our results showed that smokers were more likely to
self-medicate than the non-smoker population. This
finding was similar to that previously reported by Hagen
et al. in Norwegian adults who observed that smokers
exhibited double risk of suffering from medication overuse
headache [36]. Although experimental studies support
that nicotine has analgesic properties, epidemiologicalevidence suggests that smoking is a risk factor for chronic
pain [37].
Other factors associated with self-prescription of anal-
gesic consumption were the absence of com-morbid
conditions, only for those subjects suffering from head-
aches and excellent/good perception of health status.
Previous studies had shown that people with chronic
diseases or poor perception of health status are more
likely to use analgesic medication [14,26,38] which is in
accordance with our results. This observation may be re-
lated to cultural attitudes to pain [1] or the fact that in-
dividuals who self-medicate visit their doctor less often
since their pain is less severe. This would be of particu-
lar interest in head pain, since headaches of lower/mild
intensity can be usually controlled with analgesics. In
fact, analgesics are usually consumed by subjects with
sporadic pain symptoms. However, unnecessary anal-
gesic use should be avoided since some drugs imply spe-
cific risks and, in the case or headaches, can produce
medication overuse headache. The biggest challenge for
health care professionals remains the provision of ad-
equate pain management on an individual basis [24].
It is well accepted that pain is associated with psycho-
logical factors, particularly depression. Anxiety and de-
pression have received the main attention, mostly in
relation to recurrence and chronic pain in individuals
with low back pain due to its relationship with physical
disability and work absenteeism [9,39]. Our results
showed a statistically significant association between the
presence of psychological disorders (assessed with the SF-
36 questionnaire) and self-medication for all the types of
pain analyzed, although the strongest association was
found in individuals suffering from headaches. Our results
are in line with those previously found in Swedish people
in who chronic headache was more prevalent in subjects
who overused analgesics (39.8%) than in those who did
not (18%) [40]. This study also observed that depression
was significantly associated factor for analgesic overuse in
general (OR 3.52, 1.46-8.52) [40].
In this context, community pharmacists are important
members of health-care team. The pharmacists are prob-
ably the health professionals who are closest and most ac-
cessible to the patients and the general population. Their
opinions related to health education have an important
impact on the health of the population [41,42].
Although strengths of our study include large sample
size, a randomly selected population, the employment of
standardized survey, and training of the data collectors;
there are also a number of possible limitations. First,
since we used data from a cross-sectional survey, we
cannot determine cause and effect relationships between
the variables associated with self-prescribed medication
use. Second, the conclusions drawn are difficult to
generalize, because the survey has not been validated for
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subjective and may be subject to recall errors or a ten-
dency of subjects to give socially desirable responses in
the interviews. In addition, several of the data obtained
from the interviews were self-reported which can induce
a bias and, therefore, the prevalence of self-medication
may be underestimated. Another possible limitation is
that the survey rather than identifying specific active in-
gredients, it identifies groups of medications for specific
diseases. Nonetheless, health surveys are significantly
commended as they collect valuable information related
to musculoskeletal pain problems, which is not available
from most other sources of information.
Conclusions
This pharmacoepidemiology study constitutes an ad-
equate approach to analgesic self-medication use in the
Spanish population, based on a representative nation-
wide sample. Our study found that 23.7% of Spanish
adults use self-prescribed analgesic drug consumption to
treat their pain with the highest incidence in headache
(40.1%). We also observed that analgesic consumption
without prescription seems to be higher in young people
with higher educational level, higher monthly income,
and smoker. In addition, subjects with psychological disor-
ders and with a good perception of their health status also
self-prescribed analgesic drugs. Further, self-prescribed
analgesic consumption for headache was more frequent in
men without co-morbid chronic diseases.
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